Start-up trials headset to treat Alzheimer’s disease
The headset delivers light and sound at a frequency that improves cognitive ability.
07 December 2022
Image by Gerd Altmann from Pixabay
Cognito Therapeutics Incorporated will soon be conducting late-stage trials of a device for treating Alzheimer's disease.
The trial will involve around 500 US participants wearing a headset for an hour a day over a year.
The headset delivers light and sound at a frequency that improves cognitive ability.
The Massachusetts based start-up, will research the effects of its device on the deterioration of the brain’s white matter, the intertwining neural connections that link all four lobes of the brain.
About 10 million people are diagnosed with Alzheimer’s or other dementias each year, according to the World Health Organization.
If Cognito's headset proves effective, it could see wide adoption in 2024.
- CyberBeat
Latest News
- X u-turns to comply with Brazil court
- Taxi Apps sues Uber for launching an unlawful war to crush Australian competition
- Apple plans financial gains with with AI-centric in-house processors
- Microsoft’s free pass from government accountability
- Study reveals AI tools hold biases against women and girls
